Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.470
+0.060 (4.26%)
At close: May 1, 2026, 4:00 PM EDT
1.470
0.00 (0.00%)
Pre-market: May 4, 2026, 4:28 AM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $391.23 million as of May 1, 2026. Its market cap has increased by 8.89% in one year.
Market Cap
391.23M
Enterprise Value
432.11M
1-Year Change
8.89%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $391.23M, a decrease of -59.65%. That is a compound annual growth rate of -10.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 391.23M | -26.13% |
| Dec 31, 2025 | 529.63M | -15.31% |
| Dec 31, 2024 | 625.39M | -44.17% |
| Dec 29, 2023 | 1.12B | 240.67% |
| Dec 30, 2022 | 328.81M | -13.12% |
| Dec 31, 2021 | 378.45M | -19.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enanta Pharmaceuticals | 416.43M |
| Century Therapeutics | 415.93M |
| Benitec Biopharma | 409.35M |
| Larimar Therapeutics | 409.30M |
| vTv Therapeutics | 393.20M |
| Niagen Bioscience | 389.20M |
| Rocket Pharmaceuticals | 388.48M |
| Surrozen | 385.95M |